Picture of Celltrion logo

068270 Celltrion Income Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Annual income statement for Celltrion, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

R2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue1,893,4012,283,9672,176,4323,557,3044,162,495
Cost of Revenue
Gross Profit1,087,5941,032,6971,051,8691,681,7132,467,027
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses1,207,8441,647,1001,530,1383,054,7773,012,066
Operating Profit685,557636,867646,293502,5271,150,429
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes738,623626,173671,096576,1171,153,720
Provision for Income Taxes
Net Income After Taxes585,803531,347539,707418,8831,031,484
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income579,465537,836535,648422,6921,029,613
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income579,465537,836535,648422,6921,029,613
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS3,9073,5493,4531,7844,732
Dividends per Share